FIELD: chemistry; pharmacology.
SUBSTANCE: present invention relates to new compounds with general formula (1), which includes compounds (VI), which relate to conformational stable compounds that imitate the secondary structures of parts of molecules of biologically active peptides and proteins with reverse configurations. The compounds can be used as antitumoral compounds for the treatment and prophylaxis of cancer such as, colorectal cancer, for treating rheumatoid arthritis and ulcerative colitis. The compound facilitates the increase of apoptosis and increases the proliferation of neurites, and inhibits survirin expression in the cell. In compounds, corresponding to the general formula (I) and (VI) , in formula (I) W denotes -Y(C=O)-, -(C=O)NH-, -(SO2)- or is absent, Y denotes an oxygen atom, Z denotes a nitrogen atom or CH, X denotes a nitrogen atom or CH, n=0 or 1, on the condition that when Z denotes CH, X denotes a nitrogen atom and n=1; and when Z denotes a nitrogen atom, then n=0; in formula (VI) X1 denotes a hydroxyl, and at least one of X2 is X3 is a hydroxyl, or X1 denotes hydrogen, and X2 and X3 can be similar of different and independently selected from hydrogen, hydroxyl and halogen. Other radicals have the value specified in the formula of the invention.
EFFECT: obtaining compounds which can be used as antitumoral compounds for the treatment and prophylaxis of cancer such as, colorectal cancer, for treating rheumatoid arthritis and ulcerative colitis.
26 cl, 33 dwg, 9 tbl, 14 ex
Title | Year | Author | Number |
---|---|---|---|
MODULATION OF BETA-CATENIN/TCF-ACTIVATED TRANSCRIPTION | 2004 |
|
RU2383547C2 |
BETA-CHAIN MIMETICS AND RELATED METHODS | 2003 |
|
RU2333213C2 |
NEW COMPOUNDS MIMETICS AND USING THEM | 2008 |
|
RU2457210C2 |
ALPHA-SPIRAL MIMETICS AND METHODS ASSOCIATED WITH THEM | 2009 |
|
RU2512538C2 |
NOVEL COMPOUNDS, REPRESENTING REVERSE-TURN MIMETICS, AND THEIR APPLICATION | 2008 |
|
RU2470024C2 |
REVERSE-CONFIGURATION MIMETICS AND METHODS RELATING THERETO | 2005 |
|
RU2434017C2 |
PEPTIDE EPOXY KETONES FOR PROTEASOME INHIBITION | 2007 |
|
RU2450016C2 |
ANTICANCER AGENT | 2016 |
|
RU2729936C2 |
A CONJUGATE CONTAINING A NEUROTENSIN RECEPTOR LIGAND AND ITS APPLICATION | 2015 |
|
RU2743781C2 |
PTERIDINES EFFECTIVE AS HCV INHIBITORS AND METHODS FOR PRODUCING PTERIDINES | 2006 |
|
RU2447074C2 |
Authors
Dates
2008-12-27—Published
2004-03-17—Filed